← FDA Drug Approvals (Drugs@FDA)

VONJO

NDA · New Drug Application · Sponsor: SOBI · Approved 2022-02-28

Drug application

FDA Application #

NDA208712

Application type

New Drug Application

Brand name

VONJO

Generic name

PACRITINIB

Active ingredients

PACRITINIB CITRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SOBI

Manufacturer

Sobi, Inc.

First approval

2022-02-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown